Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium - tablet - 100 microgram(s) - thyroid hormones; levothyroxine sodium

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium - tablet - 200 microgram(s) - thyroid hormones; levothyroxine sodium

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium - tablet - 25 microgram(s) - thyroid hormones; levothyroxine sodium

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium - tablet - 50 microgram(s) - thyroid hormones; levothyroxine sodium

United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - levothyroxine sodium anhydrous (unii: 054i36cpmn) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium anhydrous 0.112 mg - levothyroxine sodium is used for the following indications: hypothyroidism - as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism. primary hypothyroidism may result from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation, or drugs, with or without the presence of goiter. pituitary tsh suppression - in the treatment or prevention of various types of euthyroid goiters (see warnings and precautions ), including thyroid nodules (see warnings and precautions ), subacute or chronic iymphocytic thyroiditis (hashimoto's thyroiditis), multinodular goiter (see warnings and precautions ), and, as an adjunct to surgery and radioiodine therapy in the managem

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 88 microgram - tablet - excipient ingredients: colloidal anhydrous silica; maize starch; magnesium stearate; purified talc; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium